Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5Lymphoid 3Plasma cell 2Other neoplasm 2Other hematologic neoplasm 2Myeloid 2Gastrointestinal 2Sarcoma 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Esophageal Neoplasms 2

Interventions

Oxaliplatin 297Fluorouracil 272Bevacizumab 235Gemcitabine 234Leucovorin 212Capecitabine 204pembrolizumab 200Nivolumab 157Irinotecan 156Cisplatin 148Specimen Handling 143Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 115Paclitaxel 109durvalumab 104Cetuximab 102Radiotherapy 96atezolizumab 92Biopsy 92Drug Therapy 91Albumin-Bound Paclitaxel 78tislelizumab 77Taxes 73Folfox protocol 68lenvatinib 67Carboplatin 65regorafenib 60Blood Specimen Collection 60trifluridine tipiracil drug combination 52Ipilimumab 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Patient Reported Outcome Measures × Gastrointestinal × 1 year × Clear all
NCT03482791 2026-04-02

Proton Beam Therapy in the Treatment of Esophageal Cancer

Washington University School of Medicine

Phase NA Active not recruiting
22 enrolled 29 charts
Gastrointestinal

Esophageal Neoplasms

NCT07211009 2025-10-07

Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial

Sichuan University

Phase 3 Not yet recruiting
240 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡